Bruker Co. (BRKR) to Issue Quarterly Dividend of $0.05 on March 28th

Bruker Co. (NASDAQ:BRKR) announced a quarterly dividend on Tuesday, February 18th, Wall Street Journal reports. Investors of record on Monday, March 17th will be given a dividend of 0.05 per share by the medical research company on Friday, March 28th. This represents a $0.20 annualized dividend and a dividend yield of 0.44%. The ex-dividend date of this dividend is Monday, March 17th.

Bruker has increased its dividend by an average of 7.7% per year over the last three years. Bruker has a dividend payout ratio of 6.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Bruker to earn $3.15 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.3%.

Bruker Stock Performance

Shares of Bruker stock opened at $45.97 on Friday. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. Bruker has a twelve month low of $44.11 and a twelve month high of $94.86. The stock has a market cap of $6.97 billion, a price-to-earnings ratio of 60.49, a P/E/G ratio of 2.16 and a beta of 1.18. The company’s fifty day moving average is $53.93 and its 200 day moving average is $58.57.

Bruker (NASDAQ:BRKR) last released its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Sell-side analysts forecast that Bruker will post 2.69 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Barclays dropped their price objective on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Bank of America upped their price objective on shares of Bruker from $78.00 to $80.00 and gave the company a “buy” rating in a report on Friday, December 13th. Stifel Nicolaus dropped their price objective on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a report on Friday, February 14th. Guggenheim restated a “buy” rating on shares of Bruker in a report on Monday, February 24th. Finally, The Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 target price on the stock in a report on Thursday, December 5th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, Bruker has an average rating of “Moderate Buy” and a consensus price target of $70.50.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.